Efficacy of Chuanxiong Ding Tong herbal formula granule in the treatment and prophylactic of migraine patients: A randomized, double-blind, multicenter, placebo-controlled trial

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Fu, Caihong ^a   Yu, Lihua ^a   Zou, Yihuai ^a   Cao, Kegang ^a   Zhao, Jianjun ^b   Gong, Haiyang ^c   Zhang, Shuquan ^d   Lin, Anji ^e   Dong, Mengjiu ^f   Yang, Wenming ^g   Li, Tao ^h   He, Liyun ⁱ   Su, Fei ^a   Wu, Ruolan ^a   Lin, Dongdong ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Taian Hospital of Traditional Chinese Medicine   (China)

^e Xiamen Hospital of Traditional Chinese Medicine   (China)

^f HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^g ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^h XIYUAN HOSPITAL   (China)

ⁱ INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CHUANXIONG DING TONG HERBAL FORMULA GRANULE; HERBACEOUS AGENT; IBUPROFEN; PHENACETIN; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CHINESE MEDICINE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EVENING DOSAGE; EYELID EDEMA; FEMALE; FOLLOW UP; HEART PALPITATION; HEMOSTASIS; HUMAN; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

EID: 84871839904     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/967968     Document Type: Article

References (28)

1. Voigt K., Liebnitzky J., Burmeister U., Sihvonen-Riemenschneider H., Beck M., Voigt R., Bergmann A., Efficacy of osteopathic manipulative treatment of female patients with migraine: results of a randomized controlled trial. Journal of Alternative and Complementary Medicine 2011 17 3 225 230 2-s2.0-79952960761 10.1089/acm.2009.0673
2. Gagne J. J., Leas B., Lofland J. H., Goldfarb N., Freitag F., Silberstein S., Quality of care measures for migraine: a comprehensive review. Disease Management 2007 10 3 138 146 2-s2.0-34548602013 10.1089/dis.2007.103639 (Pubitemid 47400544)
3. Diamond M., Dahlöf C., Papadopoulos G., Neto W., Wu S. C., Topiramate improves health-related quality of life when used to prevent migraine. Headache 2005 45 8 1023 1030 2-s2.0-33644650887 10.1111/j.1526-4610. 2005.05183.x
4. Goadsby P. J., Lipton R. B., Ferrari M. D., Migraine-current understanding and treatment. New England Journal of Medicine 2002 346 4 257 270 2-s2.0-0037165257 10.1056/NEJMra010917 (Pubitemid 34438866)
5. Engmann B., Bipolar affective disorder and migraine. Case Reports in Medicine 2012 2012 3 389851 10.1155/2012/389851
6. Bigal M. E., Lipton R. B., The epidemiology, burden, and comorbidities of migraine. Neurologic Clinics 2009 27 2 321 334 2-s2.0-61849142211 10.1016/j.ncl.2008.11.011
7. Menken M., Munsat T. L., Toole J. F., The global burden of disease study: Implications for neurology. Archives of Neurology 2000 57 3 418 420 2-s2.0-0034093231 (Pubitemid 30140537)
8. Headache Classification Subcommittee of the International Headache Society, The international classification of headache disorders: 2nd edition. Cephalalgia 2004 24 supplement 1 9 160
9. Campinha-Bacote D. L., Kendle J. B., Jones C., Callicoat D., Webert A., Stoukides C. A., Kaul A. F., Impact of a migraine management program on improving health outcomes. Disease Management 2005 8 6 382 391 2-s2.0-30844439845 10.1089/dis.2005.8.382 (Pubitemid 43107914)
10. Goadsby P. J., Sprenger T., Current practice and future directions in the prevention and acute management of migraine. The Lancet Neurology 2010 9 3 285 298 2-s2.0-76549095208 10.1016/S1474-4422(10)70005-3
11. Ramadan N. M., Silberstein S. D., Freitag F. G., Evidence based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. 2007, http://www.aan.com/professionals/ practice/pdfs/gl0090.pdf
12. Silberstein S. D., Preventive treatment of migraine. Trends in Pharmacological Sciences 2006 27 8 410 415 2-s2.0-33745892902 10.1016/j.tips.2006.06.003 (Pubitemid 44051566)
13. Lipton R. B., Stewart W. F., Cady R., Hall C., O'Quinn S., Kuhn T., Gutterman D., Sumatriptan for the range of headaches in migraine sufferers: results of the spectrum study. Headache 2000 40 10 783 791 2-s2.0-0034519937 10.1046/j.1526-4610.2000.00143.x (Pubitemid 32053238)
14. Irimia P., Palma J. A., Fernandez-Torron R., Martinez-Vila E., Refractory migraine in a headache clinic population. BMC Neurology 2011 11 article 94 2-s2.0-79960884486 10.1186/1471-2377-11-94
15. Scher A. I., Stewart W. F., Lipton R. B., Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004 63 11 2022 2027 2-s2.0-10444229748 (Pubitemid 39636246)
16. Goadsby P. J., Is medication-overuse headache a distinct biological entity? Nature Clinical Practice Neurology 2006 2 8 401 2-s2.0-33746571518 10.1038/ncpneuro0236 (Pubitemid 44137934)
17. Boon H. S., Cherkin D. C., Erro J., Sherman K. J., Milliman B., Booker J., Cramer E. H., Smith M. J., Deyo R. A., Eisenberg D. M., Practice patterns of naturopathic physicians: results from a random survey of licensed practitioners in two US States. BMC Complementary and Alternative Medicine 2004 4 article 14 2-s2.0-10444267206 10.1186/1472-6882-4-14 (Pubitemid 39637319)
18. Wang L. P., Zhang X. Z., Guo J., Liu H. L., Zhang Y., Liu C. Z., Yi J. H., Wang L. P., Zhao J. P., Li S. S., Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial. Pain 2011 152 8 1864 1871 2-s2.0-79960463224 10.1016/j.pain.2011.04.006
19. Wang L. P., Zhang X. Z., Guo J., Efficacy of acupuncture for acute migraine attack: a multicenter single blinded, randomized controlled Trial. Pain Medicine 2012 13 5 623 630 10.1111/j.1526-4637.2012.01376.x
20. Tfelt-Hansen P., Block G., Dahlöf C., Diener H. C., Ferrari M., Goadsby P., Guidetti V., Jones B., Lipton R., Massiou H., Meinert C., Sandrini G., Steiner T., Winter P., Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000 20 9 765 786 2-s2.0-0034483344 10.1046/j.1468-2982.2000.00117.x (Pubitemid 32154559)
21. World Medical Association General Assembly, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Journal International de Bioéthique 2004 15 1 124 129
22. Nestoriuc Y., Martin A., Rief W., Andrasik F., Biofeedback treatment for headache disorders: a comprehensive efficacy review. Applied Psychophysiology Biofeedback 2008 33 3 125 140 2-s2.0-52549117868 10.1007/s10484-008-9060-3
23. Hartrick C. T., Kovan J. P., Shapiro S., The numeric rating scale for clinical pain measurement: a ratio measure. Pain Practice 2003 3 4 310 316 10.1111/j.1530-7085.2003.03034.x
24. Xiong L., Fang Z. Y., Tao X. N., Bai M., Feng G., Effect and mechanism of ligustrazine on Th1/Th2 cytokines in a rat asthma model. American Journal of Chinese Medicine 2007 35 6 1011 1020 2-s2.0-37849029241 10.1142/ S0192415X07005478
25. Chang C. L., Lin C. S., Lai G. H., Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts. Evidence-Based Complementary and Alternative Medicine 2012 2012 8 984295 10.1155/2012/984295
26. Kim J. W., Han J. Y., Hong J. T., Ethanol extract of the flower Chrysanthemum morifolium augments pentobarbital-induced sleep behaviors: involvement of C l- channel activation. Evidence-Based Complementary and Alternative Medicine 2011 2011 7 2-s2.0-79953280626 10.1155/2011/109164 109164
27. Day S. J., Altman D. G., Blinding in clinical trials and other studies. British Medical Journal 2000 321 7259 504 2-s2.0-0034686811 (Pubitemid 30623610)
28. Silberstein S. D., Edlund W., Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 55 6 754 762 2-s2.0-0034718464